US 11472870
Pharmaceutical composition for safe and effective treatment of knee and/or hip pain
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11472870 (Pharmaceutical composition for safe and effective treatment of knee and/or hip pain) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/3955